We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products

News   Jun 07, 2017 | Original Story from Medherant

 
Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products
 
 
Advertisement
 

RELATED ARTICLES

The Genetic Architecture of Penicillin Allergy

News

Researchers announce the first robust evidence for the role of the major histocompatibility complex gene HLA-B in penicillin allergy to identify genetic risk factors for penicillin allergy.

READ MORE

Scientists Knock-Out All Human Genes To Identify Which Ones SARS-CoV-2 Requires

News

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

READ MORE

Trial Will Investigate if Anti-Nausea Drug Can Alleviate Hallucinations in People With Parkinson's

News

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE